Egg consumption, cardiovascular diseases and type 2 diabetes von Geiker, N R W, Larsen, M Lytken, Dyerberg, J, Stender, S, Astrup, A

Volltext

Non-Persistence with Medication as a Mediator for the Social Inequality in Risk of Major Adverse Cardiovascular Events in Patients with Incident Acute Coronary Syndrome: A Nationwi... von Boesgaard Graversen, Christina, Brink Valentin, Jan, Lytken Larsen, Mogens, Riahi, Sam, Holmberg, Teresa, Paaske Johnsen, Søren

Volltext

Socioeconomic trends in oral anticoagulation therapy for atrial fibrillation patients with low risk of stroke von Danielsen Lunde, E, Joensen, AM, Fonager, K, Lundbye-Christensen, S, Johnsen, SP, Lytken Larsen, M, Riahi, S

Volltext

Geographical and social inequalities in survival after incident acute myocardial infarction in Denmark: A spatial epidemiological cohort study based on nationwide register data von Kjaerulff, T., Bihrmann, K., Zhao, J., Exeter, D., Lytken-Larsen, M., Gislason, G.

Volltext

Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. Insights from the Incremental Decrease in End-points through Aggressive Lipi... von Holme, Ingar, Cater, Nilo B., Faergeman, Ole, Kastelein, John J. P., Olsson, Anders G., Tikkanen, Matti J., Lytken Larsen, Mogens, Lindahl, Christina, Pedersen, Terje R., on behalf of the Incremental Decrease in End-Points Through Aggressive Lipid-Lowering Study Group

Volltext

Plasma Triglycerides and Cardiovascular Events in the Treating to New Targets and Incremental Decrease in End-Points Through Aggressive Lipid Lowering Trials of Statins in Patients... von Faergeman, Ole, MD, DMSc, Holme, Ingar, PhD, Fayyad, Rana, PhD, Bhatia, Sonal, MD, Grundy, Scott M., MD, PhD, Kastelein, John J.P., MD, PhD, LaRosa, John C., MD, Larsen, Mogens Lytken, MD, DMSc, Lindahl, Christina, MD, Olsson, Anders G., MD, PhD, Tikkanen, Matti J., MD, PhD, Waters, David D., MD, Pedersen, Terje R., MD, PhD

Volltext

Hypertriglyceridemia and low HDL: therapeutic considerations von Larsen, M L

Volltext

SOCIAL INEQUALITY IN THE CONTROL OF HYPERTENSION IN A HEALTH CARE SYSTEM WITH EQUAL ACCESS: PP.7.302 von Skov Paulsen, M, Soendergaard, J, Munck, A, Gilsaa Hansen, D, Lytken Larsen, M, Abildgaard Jacobsen, I, Andersen, M

Volltext

Triglyceride-lowering agents: fibrates and nicotinic acid von Larsen, M Lytken, Illingworth, D Roger

Volltext

The Quality Needed for Measuring Glycated Haemoglobin. An Application von Petersen, P. Hyltoft, Larsen, M. Lytken, Fraser, C. G.

Volltext

Comparison of Atorvastatin 80 mg/day Versus Simvastatin 20 to 40 mg/day on Frequency of Cardiovascular Events Late (Five Years) After Acute Myocardial Infarction (from the Incremen... von Pedersen, Terje R., MD, PhD, Cater, Nilo B., MD, Faergeman, Ole, MD, DMSc, Kastelein, John J.P., MD, PhD, Olsson, Anders G., MD, PhD, Tikkanen, Matti J., MD, PhD, Holme, Ingar, PhD, Larsen, Mogens Lytken, MD, DMSc, Lindahl, Christina, MD, Szarek, Michael, PhD

Volltext

Comparison of Efficacy and Safety of Atorvastatin (80 mg) to Simvastatin (20 to 40 mg) in Patients Aged <65 Versus ≥65 Years With Coronary Heart Disease (from the Incremental DEcre... von Tikkanen, Matti J., MD, PhD, Holme, Ingar, PhD, Cater, Nilo B., MD, Szarek, Michael, PhD, Faergeman, Ole, MD, DMSc, Kastelein, John J.P., MD, PhD, Olsson, Anders G., MD, PhD, Larsen, Mogens Lytken, MD, DMSc, Lindahl, Christina, MD, Pedersen, Terje R., MD, PhD

Volltext

A 52-week, multicenter, randomized, parallel-group, double-blind, double-dummy study to assess the efficacy of atorvastatin and simvastatin in reaching low-density lipoprotein chol... von Olsson, Anders G, Eriksson, Mats, Johnson, Owe, Kjellström, Thomas, Lanke, Jan, Larsen, Mogens Lytken, Pedersen, Terje, Tikkanen, Matti J, Wiklund, Olov, 3T Study Investigators

Volltext

Comparative Effect of Atorvastatin (80 mg) Versus Simvastatin (20 to 40 mg) in Preventing Hospitalizations for Heart Failure in Patients With Previous Myocardial Infarction von Strandberg, Timo E., MD, PhD, Holme, Ingar, PhD, Faergeman, Ole, MD, DMSc, Kastelein, John J.P., MD, PhD, Lindahl, Christina, MD, Larsen, Mogens Lytken, MD, DMSc, Olsson, Anders G., MD, Pedersen, Terje R., MD, PhD, Tikkanen, Matti J., MD, PhD

Volltext

Analytical goal setting prior to selection of a method for glycated haemoglobin von Larsen, M. Lytken, Blaabjerg, O., Petersen, P. Hyltoft, Hansen, H., Hørder, M.

Volltext

Total Cardiovascular Disease Burden: Comparing Intensive With Moderate Statin Therapy von Tikkanen, Matti J., MD, PhD, Szarek, Michael, PhD, Fayyad, Rana, PhD, Holme, Ingar, PhD, Cater, Nilo B., MD, Faergeman, Ole, MD, DMSc, Kastelein, John J.P., MD, PhD, Olsson, Anders G., MD, PhD, Larsen, Mogens Lytken, MD, DMSc, Lindahl, Christina, MD, Pedersen, Terje R., MD, PhD

Volltext

High-Density Lipoprotein Cholesterol, High-Density Lipoprotein Particle Size, and Apolipoprotein A-I: Significance for Cardiovascular Risk von van der Steeg, Wim A., MD, Holme, Ingar, PhD, Boekholdt, S. Matthijs, MD, PhD, Larsen, Mogens Lytken, MD, DMSc, Lindahl, Christina, MD, Stroes, Erik S.G., MD, PhD, Tikkanen, Matti J., MD, PhD, Wareham, Nicholas J., MBBS, PhD, Faergeman, Ole, MD, DMSc, Olsson, Anders G., MD, PhD, Pedersen, Terje R., MD, PhD, Khaw, Kay-Tee, MBBChir, Kastelein, John J.P., MD, PhD

Volltext

Effect of atorvastatin and simvastatin in obtaining targets for lipids in secondary prevention. The treat-to-target study (3T) von Olsson, A.G, Eriksson, M, Johnson, O, Kjellström, T, Lanke, J, Lytken Larsen, M, Pedersen, T.R, Tikkanen, M.J, Wiklund, O

Volltext

How can we identify low- and high-risk patients among unselected patients with possible acute coronary syndrome? von Nielsen, Kirsten Melgaard, MD, PhD, Faergeman, Ole, MD, DMSc, Larsen, Mogens Lytken, MD, DMSc, Foldspang, Anders, MD, PhD, DMSc

Volltext

A Comparison of Analytical Goals for Haemoglobin A1c Assays Derived Using Different Strategies von Larsen, Mogens Lytken, Fraser, Callum G, Petersen, Per Hyltoft

Volltext